CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,651 enrolled
Drug / intervention
Oral HIV screening +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01258582
NCT01258582N/ACompleted
CompareCT.gov

Optimizing Strategies for Universal HIV Testing (The USHER Trial): Phase II

Massachusetts General Hospital·interventional·Posted Dec 13, 2010·Updated Jun 13, 2012

In Brief

A clinical study evaluating Oral HIV screening and Fingerstick HIV screening for HIV Infections. Completed, enrolled 1,651 participants across 1 site.

Detailed Summary

This study was initially designed to compare the effectiveness of two different approaches to providing routine HIV counseling, testing, and referral services in an urban hospital emergency department setting. The initial phase was closed in July 2008. The second phase of this trial consists of establishing the differences in acceptability of HIV testing based on the method of testing offered (rapid oral fluid vs. fingerstick).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHIV Infections
CountriesUnited States
CollaboratorsNational Institute of Mental Health (NIMH)

Timeline

N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedDec 13, 2010
Enrollment StartMay 1, 2009
Primary CompletionJan 1, 2010
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 15.6 years ago

Interventions

Oral HIV screeningprocedure

Participants will undergo oral HIV screening and, if positive, further study visits for up to 6 months

Fingerstick HIV screeningprocedure

Participants will undergo fingerstick HIV screening and, if positive, further study visits for up to 6 months